Article

Design of potent telomerase inhibitors using ligand-based approaches and molecular dynamics simulations studies

2024-03-13

Abstract excerpt

<title>Abstract</title> <p>Telomerase is a well-recognised and a promising target for cancer therapy. In this study, we selected ligand-based approaches to design telomerase inhibitors for the development of potent anticancer agents for future cancer therapy. Till date no telomerase inhibitors have been clinically introduced. To investigate the chemical characteristics required for telomerase inhibitory activity,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: afbfb5d2-e8e1-500a-8b62-6e19e8684c06
DOI: 10.21203/rs.3.rs-4029957/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Design of potent telomerase inhibitors using ligand-based approaches and molecular dynamics simulations studiesDOI 10.21203/rs.3.rs-4029957/v1Read

Potent Human Telomerase Inhibitors: Molecular Dynamic Simulations, Multiple Pharmacophore-Based Virtual Screening, and Biochemical AssaysSemantic proximity Read

Targeting dysregulation signatures of p53-MDM2 interactions to identify newer small molecule inhibitors for cancer therapy: Insight from computational directionSemantic proximity Read

Structural investigations of T854A mutation in EGFR and identification of novel inhibitors using structure activity relationships.Semantic proximity Read

Molecular Docking and Dynamics Simulation Study of Telomerase Inhibitors as Potential Anti-Cancer AgentsSemantic proximity Read

Structural insights into conformational stability of ESR1 and structure base screening of new potent inhibitor for the treatment of Breast CancerSemantic proximity Read

<i>In silico</i> Exploration Natural Compounds for the Discovery of Novel DNMT3A Inhibitors as Potential Therapeutic Agents for Acute Myeloid LeukemiaSemantic proximity Read

Molecular Dynamic Simulations and Binding Free Energy Evaluations of Thiazolo-[2,3-b] Quinazolinone Derivatives With wtEGFR-TKD and "TMLR" Mutant EGFR-TKDSemantic proximity Read

Computational Approaches to the Rational Design of Tubulin-Targeting AgentsSemantic proximity Read

Integrating machine learning driven virtual screening and molecular dynamics simulations to identify potential inhibitors targeting PARP1 against prostate cancerSemantic proximity Read

Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the clinical treatment of GlioblastomaSemantic proximity Read

Virtual screening, XGBoost based QSAR modelling, Molecular Docking and Molecular Dynamics Simulation approach to discover a new inhibitor targeting ErbB1 ProteinSemantic proximity Read

Exploring natural products library to identify potential inhibitors targeting isoniazid-resistant tuberculosis.Semantic proximity Read